CNS Pharmaceuticals, Inc. (CNSP) rose 35.55 percent to $1.64 on Monday following news of a $5 million public offering. The company priced 3.95 million shares at $1.265 each, along with Series F warrants exercisable at $1.14. The offering is expected to close around May 14, pending customary conditions.
Shares opened sharply higher at $2.44 and traded between $1.57 and $2.90 during the session, with volume soaring to 84.2 million well above the average of around 497,000 on the Nasdaq. The stock previously closed at $1.21 and has ranged between $0.772 and $800.00 over the past year.
Proceeds from the offering will support working capital and general corporate activities, bolstering investor sentiment around the company's ongoing cancer treatment development programs.
For comments and feedback: editorial@rttnews.com